The sirtuin family in health and disease

QJ Wu, TN Zhang, HH Chen, XF Yu, JL Lv… - Signal transduction and …, 2022 - nature.com
Sirtuins (SIRTs) are nicotine adenine dinucleotide (+)-dependent histone deacetylases
regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in …

NAD+ homeostasis in health and disease

E Katsyuba, M Romani, D Hofer, J Auwerx - Nature metabolism, 2020 - nature.com
The conceptual evolution of nicotinamide adenine dinucleotide (NAD+) from being seen as
a simple metabolic cofactor to a pivotal cosubstrate for proteins regulating metabolism and …

NAD+ Metabolism in Cardiac Health, Aging, and Disease

M Abdellatif, S Sedej, G Kroemer - Circulation, 2021 - Am Heart Assoc
Nicotinamide adenine dinucleotide (NAD+) is a central metabolite involved in energy and
redox homeostasis as well as in DNA repair and protein deacetylation reactions …

Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia

JEBF Lima, NCS Moreira, ET Sakamoto-Hojo - Mutation Research/Genetic …, 2022 - Elsevier
Abstract Type 2 diabetes (T2D) is a complex multifactorial disease that emerges from the
combination of genetic and environmental factors, and obesity, lifestyle, and aging are the …

[HTML][HTML] PARPs in lipid metabolism and related diseases

M Szántó, R Gupte, WL Kraus, P Pacher… - Progress in Lipid Research, 2021 - Elsevier
PARPs and tankyrases (TNKS) represent a family of 17 proteins. PARPs and tankyrases
were originally identified as DNA repair factors, nevertheless, recent advances have shed …

A comprehensive review of Sirtuins: With a major focus on redox homeostasis and metabolism

S Shahgaldi, FR Kahmini - Life Sciences, 2021 - Elsevier
Sirtuins are Class III protein deacetylases with seven conserved isoforms. In general,
Sirtuins are highly activated under cellular stress conditions in which NAD+ levels are …

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy

M Arow, M Waldman, D Yadin, V Nudelman… - Cardiovascular …, 2020 - Springer
Background Diabetes mellitus type 2 (DM2) is a risk factor for developing heart failure but
there is no specific therapy for diabetic heart disease. Sodium glucose transporter 2 …

[HTML][HTML] Quercetin attenuates cardiac hypertrophy by inhibiting mitochondrial dysfunction through SIRT3/PARP-1 pathway

WJ Chen, Y Cheng, W Li, XK Dong, J Wei… - Frontiers in …, 2021 - frontiersin.org
Cardiac hypertrophy is an important characteristic in the development of hypertensive heart
disease. Mitochondrial dysfunction plays an important role in the pathology of cardiac …

[HTML][HTML] Mitochondrial mechanisms in diabetic cardiomyopathy

J Gollmer, A Zirlik, H Bugger - Diabetes & metabolism journal, 2020 - ncbi.nlm.nih.gov
Mitochondrial medicine is increasingly discussed as a promising therapeutic approach,
given that mitochondrial defects are thought to contribute to many prevalent diseases and …

Sirtuin family in autoimmune diseases

Z Tao, Z Jin, J Wu, G Cai, X Yu - Frontiers in Immunology, 2023 - frontiersin.org
In recent years, epigenetic modifications have been widely researched. As humans age,
environmental and genetic factors may drive inflammation and immune responses by …